Avicanna Inc. AVCN.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · avicanna.com
Avicanna Inc. is a commercial-stage international biopharmaceutical company focused on the development, manufacturing, and commercialization of cannabinoid-based products and formulations for global medical and pharmaceutical markets. The company operates four commercial pillars: Medical Cannabis Products (RHO Phyto), a Medical Cannabis Care Platform (MyMedi.ca), a pharmaceutical pipeline, and active pharmaceutical ingredients under the Aureus Santa Marta brand.
Key ratios
FreeCashFlowOnSale TTM -0.07
FreeCashFlowOnSale 2025 -0.06
FreeCashFlowOnSale 2024 -0.12
FreeCashFlowOnSale 2023 -0.09
NetIncomeMargin TTM -0.11
NetIncomeMargin 2025 -0.11
NetIncomeMargin 2024 -0.14
NetIncomeMargin 2023 -0.52
ReturnOnAssets TTM -0.08
ReturnOnAssets 2025 -0.08
ReturnOnAssets 2024 -0.14
ReturnOnAssets 2023 -0.26
ReturnOnEquity TTM -0.26
ReturnOnEquity 2025 -0.26
ReturnOnEquity 2024 -0.41
ReturnOnEquity 2023 -1.53
Recent news
Avicanna Introduces QUIX™ Rapid-Onset Medical Cannabis Portfolio
2026-07-16 · GlobeNewswire
Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid Healthcare
2026-06-15 · GlobeNewswire
Avicanna Announces Closing of Non-Brokered Private Placement
2026-06-12 · GlobeNewswire
Avicanna Reports Q1 2026 Financial Statements
2026-05-14 · Globe and Mail
Avicanna Announces Results of Annual General and Special Meeting
2026-05-08 · GlobeNewswire
Avicanna Reports Full Year 2025 Audited Financial Statements
2026-04-01 · GlobeNewswire